Get started
Author

Jurgen B. Langenhorst

Observed names: J Langenhorst, J. B. Langenhorst, J. Langenhorst, Jurgen Langenhorst, Langenhorst, J.B., Langenhorst, Jurgen
ORCID: 0000-0001-6593-3002
Observed ORCID: 0000-0001-6593-3002
OpenAlex ID: A5026619804
Fludarabine exposure in the conditioning prior to allogeneic hematopoietic cell transplantation predicts outcomes
2019 · J. B. Langenhorst, C. van Kesteren, et al. · Blood Advances · 81
Population Pharmacokinetics of Fludarabine in Children and Adults during Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation
2018 · Jurgen B. Langenhorst, Thomas P. C. Dorlo, et al. · Clinical Pharmacokinetics · 74
PDF
CD4+ T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: a dual-center validation
2020 · Coco de Koning, Susan Prockop, et al. · Blood · 71
PDF
The influence of stem cell source on transplant outcomes for pediatric patients with acute myeloid leukemia
2019 · Amy K. Keating, Jurgen Langenhorst, et al. · Blood Advances · 66
PDF
Simultaneous quantification of busulfan, clofarabine and F-ARA-A using isotope labelled standards and standard addition in plasma by LC–MS/MS for exposure monitoring in hematopoietic cell transplantation conditioning
2017 · Arjen. M. Punt, Jurgen B. Langenhorst, et al. · Journal of Chromatography B · 42
PDF
A semi‐mechanistic model based on glutathione depletion to describe intra‐individual reduction in busulfan clearance
2020 · Jurgen B. Langenhorst, Jill Boss, et al. · British Journal of Clinical Pharmacology · 29
PDF
Predictors for Autoimmune Cytopenias after Allogeneic Hematopoietic Cell Transplantation in Children
2019 · Celina L. Szanto, Jurgen Langenhorst, et al. · Transplantation and Cellular Therapy · 29
PDF
Filgrastim enhances T-cell clearance by antithymocyte globulin exposure after unrelated cord blood transplantation
2018 · Coco de Koning, Julie-Anne Gabelich, et al. · Blood Advances · 25
PDF
Innate Immune Recovery Predicts CD4+ T Cell Reconstitution after Hematopoietic Cell Transplantation
2018 · Coco de Koning, Jurgen Langenhorst, et al. · Transplantation and Cellular Therapy · 20
Clinical Trial Simulation To Optimize Trial Design for Fludarabine Dosing Strategies in Allogeneic Hematopoietic Cell Transplantation
2020 · Jurgen B. Langenhorst, Thomas P.C. Dorlo, et al. · CPT Pharmacometrics & Systems Pharmacology · 11
PDF
Semorinemab Pharmacokinetics and The Effect on Plasma Total Tau Pharmacodynamics in Clinical Studies
2024 · Vidya Ramakrishnan, B. Bender, et al. · The Journal of Prevention of Alzheimer s Disease · 8
Sialic Acid-Engineered IL4–10 Fusion Protein is Bioactive and Rapidly Cleared from the Circulation
2019 · Cristine Steen-Louws, Peter Boross, et al. · Pharmaceutical Research · 8
PDF
Concentration QTc analysis of giredestrant: Overcoming QT /heart rate confounding in the presence of drug‐induced heart rate changes
2023 · Logan Brooks, Michael Dolton, et al. · Clinical and Translational Science · 6
PDF
Population Pharmacokinetics of Tenecteplase in Patients With Acute Myocardial Infarction and Application to Patients With Acute Ischemic Stroke
2022 · Fei Tang, Jurgen Langenhorst, et al. · The Journal of Clinical Pharmacology · 6
Exposure‐response relationships of etrolizumab in patients with moderately‐to‐severely active ulcerative colitis
2022 · Nastya Kassir, Rui Zhu, et al. · CPT Pharmacometrics & Systems Pharmacology · 5
PDF
A disease model predicting placebo response and remission status of patients with ulcerative colitis using modified Mayo score
2023 · Anita Moein, Jurgen Langenhorst, et al. · Clinical and Translational Science · 4
PDF
Optimization of a clofarabine‐based drug combination regimen for the preclinical evaluation of pediatric acute lymphoblastic leukemia
2019 · Jinhan Xie, Miriam Span, et al. · Pediatric Blood & Cancer · 4
High Exposure to Fludarabine in Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation Predicts for Impaired CD4 Reconstitution and Lower Survival Chances
2017 · Jurgen Langenhorst, Charlotte van Kesteren, et al. · Transplantation and Cellular Therapy · 3
Evaluation of standard fludarabine dosing and corresponding exposures in infants and young children undergoing hematopoietic cell transplantation
2024 · Julia Möhlmann, Lisanne van der Ploeg, et al. · Bone Marrow Transplantation · 1
The influence of TDM on achieving busulfan target exposure and related determinants, in both children and adults who underwent an allogeneic hematopoietic cell transplantation
2019 · J. Boss, J. Langenhorst, et al. · Annals of Oncology · 1
Individualized Fludarabine Dosing for Predictable Immune Reconstitution and Increased Survival Chances after Allogeneic Hematopoietic Cell Transplantation
2018 · Jurgen Langenhorst, Charlotte van Kesteren, et al. · Transplantation and Cellular Therapy · 1
Innate Immune Subset Recovery is Superior after Cord Blood Compared to Bone Marrow in Pediatric Hematopoietic Cell Transplantation and Relates to Superior Survival Chances
2017 · Coco de Koning, Jurgen Langenhorst, et al. · Transplantation and Cellular Therapy · 1
PDF
A Longitudinal Disease Progression Model Characterizing Endoscopic Response and Remission in Crohn’s Disease
2026 · Anita Moein, Jurgen Langenhorst, et al. · Journal of Pharmacokinetics and Pharmacodynamics
PDF
Standard Fludarabine Dosing Results in Overexposure in Young Children Undergoing Hematopoietic Cell Transplantation
2024 · Julia Möhlmann, Lisanne Ploeg, van der, et al. · Blood
PDF
Abstract PO4-04-11: Exposure–response analyses of GO39932: a Phase Ia/b study of giredestrant in estrogen receptor-positive, HER2-negative, locally advanced or metastatic breast cancer
2024 · Komal Jhaveri, Yi Ting (Kayla) Lien, et al. · Cancer Research
Works count: 39
Citation count: 496
H-index: 10
I10-index: 10
Year
Topic
Type